{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:13:10Z","timestamp":1784542390751,"version":"3.55.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Hemodialysis may lead to changes in serum levels of important parameters such as calcium and phosphorus, which can also affect the level of parathyroid hormone. The present study aimed to determine the prevalence and some causes of secondary hyperparathyroidism (SHPT) in hemodialysis patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS:<\/jats:title>\n                    <jats:p>\n                      The population of this descriptive-cross-sectional study included 60 hemodialysis patients admitted to the hospital in the southeast of Iran, all of whom were enrolled in the study through convenience sampling. Sociodemographic characteristics, hematologic and biochemical indices, and serum parathyroid hormone (PTH) levels were examined. A PTH hormone cut-off level of 300 picograms per deciliter was considered. Data were analyzed using an independent\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -test, Mann-Whitney U test, Chi-square test, and Fisher\u2019s exact test at a significance level of less than 0.05.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULT:<\/jats:title>\n                    <jats:p>\n                      The mean age of the participants was 53.16 \u00b1 8.60 years. Among these, 34 (56.7%) were diagnosed with SHPT, and 58 (96.7%) had underlying diseases. Additionally, 17 (28.3%) had abnormal calcium levels, 40 (66.7%) had abnormal phosphorus levels, four (6.7%) had abnormal alkaline phosphatase (ALP), and 19 (31.7%) had abnormal Ca \u00d7 P. The mean levels of PTH (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), median ALP (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.002), and Ca \u00d7 P (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.026) were significantly higher in individuals with SHPT compared to those without.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Based on the results of this study, the higher levels of ALP in hemodialysis patients with SHPT suggest that regular monitoring of laboratory tests, particularly alkaline phosphatase, can be beneficial in the follow-up of these patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jehp.jehp_2225_24","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T05:00:42Z","timestamp":1782795642000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Investigation of secondary hyperparathyroidism and its contributing factors in hemodialysis patients: A cross-sectional study"],"prefix":"10.4103","volume":"15","author":[{"given":"Mahdieh","family":"Jamshidi","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golamreza","family":"Bazmandegan","sequence":"additional","affiliation":[{"name":"Physiology-Pharmacology Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Kamiab","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Rasool","family":"Dehghani Firouzabadi","sequence":"additional","affiliation":[{"name":"Non-Communicable Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Zakeri","sequence":"additional","affiliation":[{"name":"Nursing Research Center, Kerman University of Medical Sciences, Kerman, Iran"},{"name":"Clinical Research Development Unit, Ali-Ibn Abi-Talib Hospital, Rafsanjan University of Medical Sciences, Rafsanjan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa Hamza","family":"Hermis","sequence":"additional","affiliation":[{"name":"Nursing College, Al-Qadisiyah University, AL-Dewaynia, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadya Hadi","family":"Humade","sequence":"additional","affiliation":[{"name":"Nursing College, Al-Mustaqbal University, 51001 Hillah, Babil, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Kahnooji","sequence":"additional","affiliation":[{"name":"Social Determinants of Health Research Centre, Rafsanjan University of Medical Sciences, Rafsanjan, Iran"},{"name":"Department of Internal Medicine, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6]]},"reference":[{"key":"R1-20260720","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: An update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney Int Suppl"},{"key":"R2-20260720","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/jama.2017.4046","article-title":"Assessment of global kidney health care status","volume":"317","author":"Bello","year":"2017","journal-title":"Jama"},{"key":"R3-20260720","doi-asserted-by":"crossref","first-page":"100597","DOI":"10.1016\/j.xkme.2022.100597","article-title":"CKD-associated cardiovascular mortality in the United States: Temporal trends from 1999 to 2020","volume":"5","author":"Kobo","year":"2023","journal-title":"Kidney Med"},{"key":"R4-20260720","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/1573403X14666180711124825","article-title":"Chronic kidney disease and cardiovascular disease: Is there any relationship?","volume":"15","author":"Vallianou","year":"2019","journal-title":"Curr Cardiol Rev"},{"key":"R5-20260720","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4103\/jehp.jehp_1378_23","article-title":"Knowledge, attitude, and practice regarding malnutrition amongst patients with chronic kidney disease in China: A qualitative study","volume":"13","author":"Zhu","year":"2024","journal-title":"J Educ Health Promot"},{"key":"R6-20260720","first-page":"243","article-title":"Consensus document for the detection and management of chronic kidney disease","volume":"34","author":"Mart\u00ednez-Castelao","year":"2014","journal-title":"Nefrologia"},{"key":"R7-20260720","first-page":"e12641","article-title":"Frequency of intradialytic complications in patients of end-stage renal disease on maintenance hemodialysis","volume":"13","author":"Ali","year":"2021","journal-title":"Cureus"},{"key":"R8-20260720","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4103\/jehp.jehp_273_24","article-title":"Caregiver burden and quality of life among family caregivers of hemodialysis patients from South India","volume":"13","author":"Azeez","year":"2024","journal-title":"J Educ Health Promot"},{"key":"R9-20260720","first-page":"456","article-title":"Physical and psychosocial burden experienced by women on maintenance hemodialysis","volume":"12","author":"George","year":"2023","journal-title":"J Educ Health Promot"},{"key":"R10-20260720","doi-asserted-by":"crossref","first-page":"876692","DOI":"10.3389\/fmed.2022.876692","article-title":"Severe secondary hyperparathyroidism in a chronic kidney disease patient treated with radiofrequency ablation: One case report","volume":"9","author":"Muhetaer","year":"2022","journal-title":"Front Med"},{"key":"R11-20260720","doi-asserted-by":"crossref","first-page":"F1000","DOI":"10.12688\/f1000research.22636.1","article-title":"Recent advances in understanding and managing secondary hyperparathyroidism in chronic kidney disease","volume":"9","author":"Rodr\u00edguez-Ortiz","year":"2020","journal-title":"F1000Res"},{"key":"R12-20260720","first-page":"e16388","article-title":"Secondary hyperparathyroidism in chronic kidney disease: Pathophysiology and management","volume":"13","author":"Habas","year":"2021","journal-title":"Cureus"},{"key":"R13-20260720","doi-asserted-by":"crossref","first-page":"1400891","DOI":"10.3389\/fendo.2024.1400891","article-title":"Estimating the global prevalence of secondary hyperparathyroidism in patients with chronic kidney disease","volume":"15","author":"Wang","year":"2024","journal-title":"Front Endocrinol"},{"key":"R14-20260720","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1093\/ckj\/sfab006","article-title":"Secondary hyperparathyroidism and adverse health outcomes in adults with chronic kidney disease","volume":"14","author":"Xu","year":"2021","journal-title":"Clin Kidney J"},{"key":"R15-20260720","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/ndt\/gfac236","article-title":"Treatment of secondary hyperparathyroidism in non-dialysis CKD: An appraisal 2022s","volume":"38","author":"Ketteler","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"R16-20260720","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000505501","article-title":"Is there a gender difference in clinical presentation of renal hyperparathyroidism and outcome after parathyroidectomy?","volume":"36","author":"Bures","year":"2020","journal-title":"Visc Med"},{"key":"R17-20260720","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1053\/j.ajkd.2019.07.013","article-title":"Symptoms of secondary hyperparathyroidism in patients receiving maintenance hemodialysis: A prospective cohort study","volume":"75","author":"Levy","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"R18-20260720","doi-asserted-by":"crossref","first-page":"117108","DOI":"10.1016\/j.bone.2024.117108","article-title":"Secondary hyperparathyroidism: Predictors and relationship with vitamin D status, bone turnover markers and bone mineral density","volume":"184","author":"Fitzpatrick","year":"2024","journal-title":"Bone"},{"key":"R19-20260720","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00198-011-1776-x","article-title":"Demographic, dietary, and serum factors and parathyroid hormone in the national health and nutrition examination survey","volume":"23","author":"Paik","year":"2012","journal-title":"Osteoporos Int"},{"key":"R20-20260720","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.fjs.2015.07.002","article-title":"Influence of dialysis modalities on patients undergoing parathyroidectomy for renal hyperparathyroidism","volume":"48","author":"Ho","year":"2015","journal-title":"Formosan J Surg"},{"key":"R21-20260720","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s40266-019-00696-3","article-title":"Management of secondary hyperparathyroidism in chronic kidney disease: A focus on the elderly","volume":"36","author":"Galassi","year":"2019","journal-title":"Drugs Aging"},{"key":"R22-20260720","first-page":"446","article-title":"Secondary hyperparathyroidism among Nigerians with chronic kidney disease","volume":"18","author":"Gimba","year":"2018","journal-title":"Afri Health Sci"},{"key":"R23-20260720","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11255-014-0889-5","article-title":"Secondary hyperparathyroidism is associated with pulmonary hypertension in older patients with chronic kidney disease and proteinuria","volume":"47","author":"Genctoy","year":"2015","journal-title":"Int Urol Nephrol"},{"key":"R24-20260720","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s11914-018-0486-0","article-title":"CKD-MBD: From the pathogenesis to the identification and development of potential novel therapeutic targets","volume":"16","author":"Elias","year":"2018","journal-title":"Curr Osteoporos Rep"},{"key":"R25-20260720","doi-asserted-by":"crossref","first-page":"10712","DOI":"10.21037\/apm-21-2509","article-title":"Predictive markers for severe hypocalcemia in dialysis patients with secondary hyperparathyroidism after near-total parathyroidectomy","volume":"10","author":"Zou","year":"2021","journal-title":"Ann Palliat Med"},{"key":"R26-20260720","doi-asserted-by":"crossref","first-page":"42","DOI":"10.47489\/szmc.v38i1.420","article-title":"Prevalence of secondary hyperparathyroidism in hemo-dialysis patients","author":"Amjad","year":"2024","journal-title":"Proceedings"},{"key":"R27-20260720","doi-asserted-by":"crossref","DOI":"10.1111\/1744-9987.14230","article-title":"Real world evaluation of etelcalcetide in the treatment of secondary hyperparathyroidism in hemodialysis patients in Argentina","author":"Wojtowicz","year":"2024","journal-title":"Ther Apher Dial"},{"key":"R28-20260720","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000491041","article-title":"Secondary and tertiary hyperparathyroidism","volume":"51","author":"Messa","year":"2019","journal-title":"Parathyroid Disord"},{"key":"R29-20260720","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/1744-9987.12772","article-title":"Secondary hyperparathyroidism: Pathogenesis and latest treatment","volume":"23","author":"Mizobuchi","year":"2019","journal-title":"Ther Apher Dial"},{"key":"R30-20260720","doi-asserted-by":"crossref","first-page":"422","DOI":"10.7326\/M17-2640","article-title":"Diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder: Synopsis of the kidney disease: Improving global outcomes 2017 clinical practice guideline update","volume":"168","author":"Ketteler","year":"2018","journal-title":"Ann Intern Med"},{"key":"R31-20260720","first-page":"1","article-title":"Kidney disease: Improving global outcomes (KDIGO) CKD-MBD update work group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder (CKD-MBD)","volume":"7","author":"Garabed","year":"2017","journal-title":"Kidney Int Suppl"}],"container-title":["Journal of Education and Health Promotion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/jehp.jehp_2225_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:00:53Z","timestamp":1784541653000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.4103\/jehp.jehp_2225_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jehp.jehp_2225_24","relation":{},"ISSN":["2277-9531","2319-6440"],"issn-type":[{"value":"2277-9531","type":"print"},{"value":"2319-6440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"2024-12-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}